ArticleJournal of hepatocellular carcinoma2025

TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study.

Caiyun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.